Cargando…
Acetylsalicylic acid in critically ill patients: a cross‐sectional and a randomized trial
BACKGROUND: Despite decades of clinical use, the pharmacokinetics and the effects of acetylsalicylic acid (ASA) in critically ill patients remain ill‐defined. We aimed to investigate the pharmacokinetics and the effects of different ASA formulations during critical illness. DESIGN: A cross‐sectional...
Autores principales: | Schoergenhofer, Christian, Hobl, Eva‐Luise, Schwameis, Michael, Gelbenegger, Georg, Staudinger, Thomas, Heinz, Gottfried, Speidl, Walter S., Zauner, Christian, Reiter, Birgit, Lang, Irene, Jilma, Bernd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519937/ https://www.ncbi.nlm.nih.gov/pubmed/28556061 http://dx.doi.org/10.1111/eci.12771 |
Ejemplares similares
-
Prasugrel in critically ill patients
por: Schoergenhofer, Christian, et al.
Publicado: (2017) -
Clopidogrel in Critically Ill Patients
por: Schoergenhofer, Christian, et al.
Publicado: (2017) -
Morphine interaction with prasugrel: a double-blind, cross-over trial in healthy volunteers
por: Hobl, Eva-Luise, et al.
Publicado: (2015) -
Bridging the Missing Link with Emicizumab: A Bispecific Antibody for Treatment of Hemophilia A
por: Gelbenegger, Georg, et al.
Publicado: (2020) -
Multi-phasic life-threatening anaphylaxis refractory to epinephrine managed by extracorporeal membrane oxygenation (ECMO): A case report
por: Grafeneder, Juergen, et al.
Publicado: (2022)